Cargando…
Correction: Tumor driven by gain-of-function HER2 H878Y mutant is highly sensitive to HER2 inhibitor
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219658/ https://www.ncbi.nlm.nih.gov/pubmed/30443295 http://dx.doi.org/10.18632/oncotarget.26252 |
_version_ | 1783368692517568512 |
---|---|
author | Hu, Zexi Hu, Yong Liu, Xicheng Xi, Rongwen Zhang, Aiqun Liu, Deruo Xie, Qiang Chen, Liang |
author_facet | Hu, Zexi Hu, Yong Liu, Xicheng Xi, Rongwen Zhang, Aiqun Liu, Deruo Xie, Qiang Chen, Liang |
author_sort | Hu, Zexi |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6219658 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-62196582018-11-15 Correction: Tumor driven by gain-of-function HER2 H878Y mutant is highly sensitive to HER2 inhibitor Hu, Zexi Hu, Yong Liu, Xicheng Xi, Rongwen Zhang, Aiqun Liu, Deruo Xie, Qiang Chen, Liang Oncotarget Correction Impact Journals LLC 2018-10-16 /pmc/articles/PMC6219658/ /pubmed/30443295 http://dx.doi.org/10.18632/oncotarget.26252 Text en Copyright: © 2018 Hu et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Correction Hu, Zexi Hu, Yong Liu, Xicheng Xi, Rongwen Zhang, Aiqun Liu, Deruo Xie, Qiang Chen, Liang Correction: Tumor driven by gain-of-function HER2 H878Y mutant is highly sensitive to HER2 inhibitor |
title | Correction: Tumor driven by gain-of-function HER2 H878Y mutant is highly sensitive to HER2 inhibitor |
title_full | Correction: Tumor driven by gain-of-function HER2 H878Y mutant is highly sensitive to HER2 inhibitor |
title_fullStr | Correction: Tumor driven by gain-of-function HER2 H878Y mutant is highly sensitive to HER2 inhibitor |
title_full_unstemmed | Correction: Tumor driven by gain-of-function HER2 H878Y mutant is highly sensitive to HER2 inhibitor |
title_short | Correction: Tumor driven by gain-of-function HER2 H878Y mutant is highly sensitive to HER2 inhibitor |
title_sort | correction: tumor driven by gain-of-function her2 h878y mutant is highly sensitive to her2 inhibitor |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219658/ https://www.ncbi.nlm.nih.gov/pubmed/30443295 http://dx.doi.org/10.18632/oncotarget.26252 |
work_keys_str_mv | AT huzexi correctiontumordrivenbygainoffunctionher2h878ymutantishighlysensitivetoher2inhibitor AT huyong correctiontumordrivenbygainoffunctionher2h878ymutantishighlysensitivetoher2inhibitor AT liuxicheng correctiontumordrivenbygainoffunctionher2h878ymutantishighlysensitivetoher2inhibitor AT xirongwen correctiontumordrivenbygainoffunctionher2h878ymutantishighlysensitivetoher2inhibitor AT zhangaiqun correctiontumordrivenbygainoffunctionher2h878ymutantishighlysensitivetoher2inhibitor AT liuderuo correctiontumordrivenbygainoffunctionher2h878ymutantishighlysensitivetoher2inhibitor AT xieqiang correctiontumordrivenbygainoffunctionher2h878ymutantishighlysensitivetoher2inhibitor AT chenliang correctiontumordrivenbygainoffunctionher2h878ymutantishighlysensitivetoher2inhibitor |